Wynzora
Wynzora is a skin care medication containing Betamethasone + Calcipotriol, available as 0.05/0.005% tubes.
- Category
- Skin Care
- Active ingredient
- Betamethasone · Calcipotriol
- Route
- Cutaneous use
- Form
- Cream
- Strengths
- 0.05/0.005%
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Wynzora vary by country.
Details
- Conditions
- Plaque psoriasis
- Therapeutic Class
- Corticosteroid, Vitamin D analogue
- Pharmacological Class
- Glucocorticoids, Vitamin D3 derivative
- Minor Side Effects
- pruritus, skin irritation
- Moderate Side Effects
- folliculitis, skin atrophy, pigmentary changes
- Dosage Forms
- Cream
- Administration Route
- Cutaneous use
- Prescription Status
- Available without prescription
- Originator
- LEO Pharma
- Onset Time
- 1–2 weeks
- Duration
- up to 8 weeks
- Storage Instructions
- Store below 25°C.
- Age Restrictions
- Not for children under 18 years.
What you will receive
Wynzora is the originator brand name, made by LEO Pharma. We use it here to identify the medicine only; we are not affiliated with LEO Pharma and do not ship the original Wynzora.
- You receive a generic equivalent: the same active ingredient (Betamethasone / Calcipotriol) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.